SynthesisBMC health services research2024
Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis.
Mehdi Rezaee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.